Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)

Condition:   Thromboembolism
Interventions:   Drug: Dabigatran etexilate;   Drug: Warfarin
Sponsor:   Boehringer Ingelheim
Not yet recruiting - verified September 2016

Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis

Conditions:   Hemoptysis;   Haemoptysis;   Lung Disease;   Pneumonia;   Tuberculosis;   Bronchiectasis;   Respiratory Tract Infections;   Respiratory Tract Diseases;   Bronchitis;   Mycobacterium Infections;   Bronchial Disease;   Pulmonary Hemorrhage;   Signs and Symptoms;   Signs and Symptoms, Respiratory;   Pathologic Processes;   Mycosis;   Hemorrhage;   Lung Cancer;   Pulmonary Embolism;   Arteriovenous Fistula
Intervention:  
Sponsor:   Université de Sherbrooke
Recruiting - verified September 2016

Safety and Efficacy of IV TXA in Reducing Blood Loss and Transfusion in Hip Fractures

Conditions:   Hip Fractures;   Blood Loss
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsor:   Yale University
Not yet recruiting - verified September 2016

Iodine Mapping Using Subtraction in Pulmonary Embolism CT Versus Dual-Energy CT

Condition:   Pulmonary Embolism
Intervention:   Device: Iodine Mapping using Subtraction in Pulmonary Embolism Computed Tomography versus Dual Energy Computed Tomography
Sponsor:   Radboud University
Recruiting - verified August 2016

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Condition:   Venous Thrombosis and Pulmonary Embolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY 59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Not yet recruiting - verified September 2016

Direct Evaluation of Postoperative Myocardial Injury Using Coronary Computed Tomography Angiography After Non-Cardiac Surgery

Condition:   Postoperative Myocardial Injury
Intervention:   Radiation: Coronary Computed Tomography Angiography
Sponsor:   UMC Utrecht
Enrolling by invitation - verified September 2016

New International CTEPH Database

Conditions:   Chronic Thromboembolic Pulmonary Hypertension;   CTEPH
Intervention:  
Sponsor:   International CTEPH Association
Active, not recruiting - verified September 2016

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Condition:   Venous Thromboembolism
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified September 2016

Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)

Condition:   Venous Thromboembolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor:   Bayer
Recruiting - verified September 2016

A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban;   Drug: Standard-of-care
Sponsors:   Janssen Scientific Affairs, LLC;   Bayer
Recruiting - verified September 2016

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Condition:   Neoplasms
Interventions:   Drug: Rivaroxaban;   Drug: Placebo
Sponsors:   Janssen Research & Development, LLC;   Bayer
Recruiting - verified September 2016

Frail Status of Elderly Patients After Repair and Anesthesia Guided by the bispectraL Index

Conditions:   Anesthesia, General;   Aged, 70 and Over
Interventions:   Other: Toolbox: Automated group;   Other: Manual group
Sponsor:   Hopital Foch
Recruiting - verified September 2016

Enoxaparin Metabolism in Reconstructive Surgery Patients

Conditions:   Venous Thromboembolism;   Deep Venous Thrombosis;   Pulmonary Embolus;   Reconstructive Surgery
Intervention:   Drug: Enoxparin
Sponsor:   University of Utah
Completed - verified September 2016

Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

Condition:   Pulmonary Embolism
Intervention:   Device: IVC Filter
Sponsors:   New England Research Institutes;   IVC Filter Study Group Foundation (IDE Sponsor);   ALN Implants Chirurgicaux;   B. Braun Interventional Systems, Inc;   Bard Peripheral Vascular, Inc.;   Cook;   Cordis Corporation;   Rex Medical
Recruiting - verified October 2015

Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE

Conditions:   Elderly;   Pulmonary Embolism;   Anticoagulants
Intervention:   Other: 4 blood samples
Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   Ministry of Health, France
Recruiting - verified September 2016

PERCEPIC: PERC Rule Combined With Implicit Low Clinical Probability

Conditions:   Pulmonary Embolism;   Dyspnea;   Thoracic Pain
Intervention:   Other: Gestalt estimation
Sponsors:   University Hospital, Angers;   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Completed - verified September 2016

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Placebo
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified September 2016

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Epoetin alfa
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified September 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin
Sponsor:   Bayer
Recruiting - verified September 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified September 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified September 2016

GLORIA-AF Registry Program (Phase II/III)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Active, not recruiting - verified September 2016

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Recruiting - verified August 2016

STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial

Conditions:   Intracerebral Haemorrhage;   Stroke
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsor:   Neuroscience Trials Australia
Recruiting - verified September 2016

Diclofenac for Submassive PE

Condition:   Pulmonary Embolism
Interventions:   Drug: Diclofenac;   Drug: Placebo
Sponsor:   Ministry of Health, Spain
Terminated - verified September 2016

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified September 2016

Clinical Randomisation of an Antifibrinolytic in Significant Head Injury

Condition:   Traumatic Brain Injury
Intervention:   Drug: Tranexamic Acid
Sponsor:   London School of Hygiene and Tropical Medicine
Recruiting - verified September 2016

Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)

Condition:   Ankylosing Spondylitis
Intervention:  
Sponsor:   Merck Sharp & Dohme Corp.
Active, not recruiting - verified September 2016